Moderna Inc’s recently made public that its Director AFEYAN NOUBAR unloaded Company’s shares for reported $1.53 million on Apr 03 ’24. In the deal valued at $101.68 per share,15,000 shares were sold. As a result of this transaction, AFEYAN NOUBAR now holds 2,086,931 shares worth roughly $219.32 million.
Then, AFEYAN NOUBAR sold 15,000 shares, generating $1,635,864 in total proceeds. Upon selling the shares at $109.06, the Director now owns 2,101,931 shares.
Before that, AFEYAN NOUBAR sold 15,000 shares. Moderna Inc shares valued at $1,535,820 were divested by the Director at a price of $102.39 per share. As a result of the transaction, AFEYAN NOUBAR now holds 2,116,931 shares, worth roughly $222.47 million.
HSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was increased to $86 from $75. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early January from “a Perform” to “an Outperform”. Canaccord Genuity began covering MRNA with “Hold” recommendation on November 29, 2023. HSBC Securities revised its rating on November 03, 2023. It rated MRNA as “a Hold” which previously was an “a Reduce”.
Price Performance Review of MRNA
On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock jump 2.15% to $105.09. Over the last five days, the stock has lost -0.48%. Moderna Inc shares have risen nearly 5.67% since the year began. Nevertheless, the stocks have fallen -32.03% over the past one year. While a 52-week high of $163.24 was reached on 01/08/24, a 52-week low of $62.55 was recorded on 02/13/24. SMA at 50 days reached $99.48, while 200 days put it at $99.71. A total of 2.06 million shares were traded, compared to the trading of 5.17 million shares in the previous session.
Levels Of Support And Resistance For MRNA Stock
The 24-hour chart illustrates a support level at 102.36, which if violated will result in even more drops to 99.63. On the upside, there is a resistance level at 106.52. A further resistance level may holdings at 107.96. The Relative Strength Index (RSI) on the 14-day chart is 53.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.82, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.07%. Stochastics %K at 42.76% indicates the stock is a holding.
How much short interest is there in Moderna Inc?
A steep rise in short interest was recorded in Moderna Inc stocks on Mar 15, 2024, dropping by -1.85 million shares to a total of 22.23 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 24.08 million shares. There was a decline of -8.32%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 7.65% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.78.
